Personal information

No personal information available

Activities

Works (5)

HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy

Nature Communications
2024-07-02 | Journal article
Contributors: Guinevere Q. Lee; Pragya Khadka; Sarah N. Gowanlock; Dennis C. Copertino, Jr; Maggie C. Duncan; F. Harrison Omondi; Natalie N. Kinloch; Jingo Kasule; Taddeo Kityamuweesi; Paul Buule et al.
Source: check_circle
Crossref

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size

2023-10-09 | Preprint
Contributors: Maggie C. Duncan; F. Harrison Omondi; Natalie N. Kinloch; Hope R. Lapointe; Sarah Speckmaier; Nadia Moran-Garcia; Tanya Lawson; Mari L. DeMarco; Janet Simons; Daniel T. Holmes et al.
Source: check_circle
Crossref

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose

2022-01-06 | Preprint
Contributors: Francis Mwimanzi; Hope R. Lapointe; Peter K. Cheung; Yurou Sang; Fatima Yaseen; Gisele Umviligihozo; Rebecca Kalikawe; Sneha Datwani; F. Harrison Omondi; Laura Burns et al.
Source: check_circle
Crossref

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy

mBio
2021-12-21 | Journal article
Contributors: F. Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N. Kinloch; Bradley R. Jones; Rachel L. Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A. Brockman et al.
Source: check_circle
Crossref

HIV proviral burden, genetic diversity, and dynamics in viremic controllers who subsequently initiated suppressive antiretroviral therapy

2021-03-30 | Preprint
Contributors: F. Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N. Kinloch; Bradley R. Jones; Rachel L. Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A. Brockman et al.
Source: check_circle
Crossref